Comments on the EASL practice guidelines for the management of chronic hepatitis B: Controversies in interferon-based therapy

被引：3
|
作者：
Janssen, Harry L. A. [1 ]
Buster, Eric H. C. J. [1 ]
机构：
[1] Univ Med Ctr Rotterdams, Erasmus MC, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 51卷 / 01期
关键词：
TERM-FOLLOW-UP; HBEAG-POSITIVE PATIENTS; FUMARATE TDF TREATMENT; ADV SWITCH DATA; PEGINTERFERON ALPHA-2A; LAMIVUDINE THERAPY; SUSTAINED HBEAG; VIRUS DNA; DURABILITY; SEROCONVERSION;
D O I：
10.1016/j.jhep.2009.02.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：224 / 226
页数：3
相关论文
共 50 条
  • [1] EASL Clinical Practice Guidelines: Management of chronic hepatitis B
    Marcellin, Patrick
    Dusheiko, Geoffrey
    Zoulim, Fabien
    Esteban, Rafael
    Hadziyannis, Stefanos
    Lampertico, Pietro
    Manns, Michael
    Shouval, Daniel
    Yurdaydin, Cihan
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 (02) : 227 - 242
  • [2] EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
    Papatheodoridis, George
    Buti, Maria
    Cornberg, Markus
    Janssen, Harry
    Mutimer, David
    Pol, Stanislas
    Raimondo, Giovanni
    [J]. JOURNAL OF HEPATOLOGY, 2012, 57 (01) : 167 - 185
  • [3] EASL clinical practice guidelines on the management of chronic hepatitis B: The need for liver biopsy
    Papatheodoridis, George V.
    Manolakopoulos, Spilios
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (01) : 226 - 227
  • [4] PREDICTORS OF SUSTAINED RESPONSE TO INTERFERON-BASED THERAPY IN CHRONIC HEPATITIS B
    Jelev, Deian
    Antonov, Krasimir
    Ivanova, Aneta
    Krastev, Zahariy
    [J]. JOURNAL OF IMAB, 2011, 17 (01): : 154 - 157
  • [5] EASL Clinical Practice Guidelines. Management of chronic hepatitis B European Association for the Study of the Liver
    European Association for the Study of the Liver
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (6-7): : 539 - 554
  • [6] EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
    Lampertico P.
    Agarwal K.
    Berg T.
    Buti M.
    Janssen H.L.A.
    Papatheodoridis G.
    Zoulim F.
    Tacke F.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 370 - 398
  • [7] The prevalence of occult hepatitis B in chronic hepatitis C patients treated with interferon-based antiviral therapy
    Bal, Tayibe
    Onlen, Yusuf
    [J]. ARAB JOURNAL OF GASTROENTEROLOGY, 2018, 19 (01) : 33 - 36
  • [8] Interferon-based therapy of hepatitis C
    Chevaliez, Stephane
    Pawlotsky, Jean-Michel
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (12) : 1222 - 1241
  • [9] Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?
    Lau, George K. K.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 (01) : 6 - 8
  • [10] Experience with neuropsychiatric complications of interferon-based therapy for chronic viral hepatitis
    Mullen, KD
    [J]. ENCEPHALOPATHY AND NITROGEN METABOLISM IN LIVER FAILURE, 2003, : 153 - 157
12345